Complete financial analysis of Clever Leaves Holdings Inc. (CLVR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Clever Leaves Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Nantong Jianghai Capacitor Co. Ltd. (002484.SZ) Income Statement Analysis – Financial Results
- Intercontinental Gold and Metals Ltd. (GXMLF) Income Statement Analysis – Financial Results
- Panchmahal Steel Limited (PANCHMAHQ.BO) Income Statement Analysis – Financial Results
- Global Payment Technologies Inc. (GPTX) Income Statement Analysis – Financial Results
- Science Strategic Acquisition Corp. Alpha (SSAA) Income Statement Analysis – Financial Results
Clever Leaves Holdings Inc. (CLVR)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cleverleaves.com
About Clever Leaves Holdings Inc.
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17.42M | 17.80M | 15.37M | 12.12M | 7.83M | 0.00 |
| Cost of Revenue | 10.86M | 13.47M | 8.57M | 4.70M | 4.73M | 99.00K |
| Gross Profit | 6.56M | 4.33M | 6.81M | 7.41M | 3.10M | -99.00K |
| Gross Profit Ratio | 37.64% | 24.33% | 44.29% | 61.18% | 39.60% | 0.00% |
| Research & Development | 1.14M | 1.72M | 1.55M | 1.01M | 0.00 | 0.00 |
| General & Administrative | 17.99M | 27.82M | 38.40M | 29.83M | 34.98M | 4.75M |
| Selling & Marketing | 2.04M | 1.90M | 3.80M | 2.58M | 3.18M | 417.00K |
| SG&A | 20.03M | 29.71M | 42.19M | 32.41M | 38.16M | 5.31M |
| Other Expenses | 0.00 | 2.06M | 1.77M | 1.85M | 1.48M | 0.00 |
| Operating Expenses | 21.17M | 33.49M | 45.51M | 34.26M | 39.64M | 5.31M |
| Cost & Expenses | 33.01M | 46.96M | 54.07M | 38.96M | 44.37M | 5.41M |
| Interest Income | 0.00 | 2.70M | 6.82M | 4.46M | 2.68M | 390.00K |
| Interest Expense | 46.00K | 2.70M | 6.82M | 4.46M | 2.68M | 0.00 |
| Depreciation & Amortization | 2.85M | 3.67M | 3.51M | 3.59M | 1.48M | 99.00K |
| EBITDA | -16.84M | -35.80M | -35.19M | -23.26M | -41.72M | -5.31M |
| EBITDA Ratio | -96.66% | -144.33% | -225.63% | -203.91% | -454.35% | 0.00% |
| Operating Income | -15.59M | -29.16M | -38.70M | -26.85M | -36.54M | -5.41M |
| Operating Income Ratio | -89.53% | -163.82% | -251.72% | -221.56% | -466.43% | 0.00% |
| Total Other Income/Expenses | -4.14M | -15.00M | -5.98M | 951.00K | -9.34M | 13.15M |
| Income Before Tax | -19.73M | -72.46M | -44.68M | -36.68M | -45.88M | 7.74M |
| Income Before Tax Ratio | -113.27% | -407.05% | -290.63% | -302.67% | -585.70% | 0.00% |
| Income Tax Expense | 68.00K | -6.35M | 950.00K | 4.74M | 2.25M | -126.00K |
| Net Income | -17.90M | -66.10M | -45.63M | -41.41M | -48.13M | 7.36M |
| Net Income Ratio | -102.77% | -371.35% | -296.81% | -341.78% | -614.37% | 0.00% |
| EPS | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| EPS Diluted | -11.42 | -51.65 | -53.29 | -49.93 | -184.77 | 0.00 |
| Weighted Avg Shares Out | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
| Weighted Avg Shares Out (Dil) | 1.57M | 1.28M | 856.34K | 829.43K | 260.49K | 0.00 |
Here's Why Cannabis-Related Stock Clever Leaves Is Rising During Thursday's After-Hours Session
Clever Leaves Holdings Inc (NASDAQ: CLVR) shares are trading higher by 9.5% to $1.73 during Thursday's after-hours session after the company reported better-than-expected fourth-quarter sales results and reaffirmed FY22 guidance. Clever Leaves Holdings reported quarterly sales of $4.
Will The Cannabis Legalization Bill Affect Penny Stocks? 3 to Watch
Check these 3 marijuana penny stocks out ahead of new cannabis legislation The post Will The Cannabis Legalization Bill Affect Penny Stocks? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Marijuana Penny Stocks Right Now? 3 With Analysts Forecasting Upside
Are You Looking For Penny Stocks To Trade Right Now? The post Top Marijuana Penny Stocks Right Now? 3 With Analysts Forecasting Upside appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Cannabis Sector Kicks Off March With a Blast of Q4 Earnings
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
11 Marijuana Stocks on Fire to Close February
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
These Pot Stocks Made Major International Moves This Week
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.
Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership
Alan Brochstein's 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in...
Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower
Clever Leaves Holdings Inc. (NASDAQ:CLVR) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement.
Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO
Clever Leaves Holdings Inc. CLVR reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook. Q4 2021 Financial Estimates vs.
Marijuana Stocks To Buy For 2022 On The Nasdaq? 2 For Your Watchlist To Start The New Year
Pot Stocks For 2022 on The Nasdaq The post Marijuana Stocks To Buy For 2022 On The Nasdaq? 2 For Your Watchlist To Start The New Year appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a...
Source: https://incomestatements.info
Category: Stock Reports